Revenue Summary of Pfizer Inc.

Pfizer Inc.'s latest annual revenue in 2023 was 58.49 Billion USD , down -41.7% from previous year.
Pfizer Inc.'s latest quarterly revenue in 2024 Q3 was 17.7 Billion USD , up 33.27% from previous quarter.
Pfizer Inc. reported a annual revenue of 100.33 Billion USD in annual revenue 2022, up 23.43% from previous year.
Pfizer Inc. reported a annual revenue of 81.28 Billion USD in annual revenue 2021, up 93.97% from previous year.
Pfizer Inc. reported a quarterly revenue of 13.28 Billion USD for 2024 Q2, down -10.73% from previous quarter.
Pfizer Inc. reported a quarterly revenue of 17.7 Billion USD for 2024 Q3, up 33.27% from previous quarter.

Annual Revenue Chart of Pfizer Inc. (2023 - 1989)

Historical Annual Revenue of Pfizer Inc. (2023 - 1989)

Year	Revenue	Revenue Growth
2023	58.49 Billion USD	-41.7%
2022	100.33 Billion USD	23.43%
2021	81.28 Billion USD	93.97%
2020	41.9 Billion USD	-19.02%
2019	51.75 Billion USD	-3.54%
2018	53.64 Billion USD	2.1%
2017	52.54 Billion USD	-0.53%
2016	52.82 Billion USD	8.13%
2015	48.85 Billion USD	-1.52%
2014	49.6 Billion USD	-3.84%
2013	51.58 Billion USD	-12.55%
2012	58.98 Billion USD	-12.52%
2011	67.42 Billion USD	-0.57%
2010	67.8 Billion USD	35.59%
2009	50 Billion USD	3.55%
2008	48.29 Billion USD	-0.25%
2007	48.41 Billion USD	0.1%
2006	48.37 Billion USD	-5.71%
2005	51.29 Billion USD	-2.32%
2004	52.51 Billion USD	16.22%
2003	45.18 Billion USD	39.59%
2002	32.37 Billion USD	0.35%
2001	32.25 Billion USD	9.08%
2000	29.57 Billion USD	82.51%
1999	16.2 Billion USD	19.64%
1998	13.54 Billion USD	8.32%
1997	12.5 Billion USD	10.6%
1996	11.3 Billion USD	12.82%
1995	10.02 Billion USD	21.01%
1994	8.28 Billion USD	10.75%
1993	7.47 Billion USD	3.42%
1992	7.23 Billion USD	4.03%
1991	6.95 Billion USD	8.49%
1990	6.4 Billion USD	12.95%
1989	5.67 Billion USD	5.31%

Year	Revenue	Revenue Growth
2024 Q1	14.87 Billion USD	4.42%
2024 Q2	13.28 Billion USD	-10.73%
2024 Q3	17.7 Billion USD	33.27%
2023 FY	58.49 Billion USD	-41.7%
2023 Q1	18.28 Billion USD	-24.73%
2023 Q2	12.73 Billion USD	-30.35%
2023 Q3	13.23 Billion USD	3.91%
2023 Q4	14.24 Billion USD	7.69%
2022 Q3	22.63 Billion USD	-18.4%
2022 Q1	25.66 Billion USD	7.65%
2022 Q2	27.74 Billion USD	8.11%
2022 FY	100.33 Billion USD	23.43%
2022 Q4	24.29 Billion USD	7.3%
2021 Q1	14.58 Billion USD	24.8%
2021 Q2	18.97 Billion USD	30.14%
2021 Q4	23.83 Billion USD	-1.06%
2021 Q3	24.09 Billion USD	26.96%
2021 FY	81.28 Billion USD	93.97%
2020 Q1	12.02 Billion USD	-5.2%
2020 Q4	11.68 Billion USD	-3.68%
2020 Q3	12.13 Billion USD	2.8%
2020 Q2	11.8 Billion USD	-1.89%
2020 FY	41.9 Billion USD	-19.02%
2019 Q1	13.11 Billion USD	-6.14%
2019 FY	51.75 Billion USD	-3.54%
2019 Q4	12.68 Billion USD	0.06%
2019 Q3	12.68 Billion USD	-4.4%
2019 Q2	13.26 Billion USD	1.11%
2018 Q2	13.46 Billion USD	4.34%
2018 Q1	12.9 Billion USD	-5.82%
2018 FY	53.64 Billion USD	2.1%
2018 Q4	13.97 Billion USD	5.1%
2018 Q3	13.29 Billion USD	-1.25%
2017 Q1	12.77 Billion USD	-6.22%
2017 Q4	13.7 Billion USD	4.06%
2017 Q3	13.16 Billion USD	2.11%
2017 Q2	12.89 Billion USD	0.92%
2017 FY	52.54 Billion USD	-0.53%
2016 FY	52.82 Billion USD	8.13%
2016 Q4	13.62 Billion USD	4.46%
2016 Q2	13.14 Billion USD	1.09%
2016 Q3	13.04 Billion USD	-0.78%
2016 Q1	13 Billion USD	-7.42%
2015 Q1	10.86 Billion USD	-17.18%
2015 Q2	11.85 Billion USD	9.1%
2015 Q3	12.08 Billion USD	1.97%
2015 FY	48.85 Billion USD	-1.52%
2015 Q4	14.04 Billion USD	16.22%
2014 Q3	12.36 Billion USD	-3.23%
2014 Q2	12.77 Billion USD	12.51%
2014 Q1	11.35 Billion USD	-16.26%
2014 FY	49.6 Billion USD	-3.84%
2014 Q4	13.11 Billion USD	6.12%
2013 Q4	13.55 Billion USD	7.24%
2013 Q3	12.64 Billion USD	-2.54%
2013 Q2	12.97 Billion USD	-3.9%
2013 FY	51.58 Billion USD	-12.55%
2013 Q1	13.5 Billion USD	-10.41%
2012 Q1	15.4 Billion USD	-8.01%
2012 Q2	15.05 Billion USD	-2.26%
2012 Q3	13.97 Billion USD	-7.18%
2012 Q4	15.06 Billion USD	7.81%
2012 FY	58.98 Billion USD	-12.52%
2011 Q2	16.98 Billion USD	2.92%
2011 FY	67.42 Billion USD	-0.57%
2011 Q4	16.74 Billion USD	-2.6%
2011 Q3	17.19 Billion USD	1.23%
2011 Q1	16.5 Billion USD	-6.03%
2010 Q1	16.75 Billion USD	1.29%
2010 FY	67.8 Billion USD	35.59%
2010 Q4	17.56 Billion USD	8.6%
2010 Q3	16.17 Billion USD	-6.67%
2010 Q2	17.32 Billion USD	3.44%
2009 Q4	16.53 Billion USD	42.3%
2009 Q2	10.98 Billion USD	1.08%
2009 Q1	10.86 Billion USD	-11.98%
2009 Q3	11.62 Billion USD	5.8%
2009 FY	50 Billion USD	3.55%
2008 Q4	12.34 Billion USD	3.12%
2008 Q2	12.12 Billion USD	2.37%
2008 FY	48.29 Billion USD	-0.25%
2008 Q3	11.97 Billion USD	-1.29%
2008 Q1	11.84 Billion USD	-7.94%
2007 Q1	12.47 Billion USD	-1.02%
2007 Q3	11.99 Billion USD	8.17%
2007 FY	48.41 Billion USD	0.1%
2007 Q2	11.08 Billion USD	-11.14%
2007 Q4	12.87 Billion USD	7.34%
2006 Q4	12.6 Billion USD	2.63%
2006 Q2	11.74 Billion USD	-7.26%
2006 Q1	12.66 Billion USD	-6.86%
2006 FY	48.37 Billion USD	-5.71%
2006 Q3	12.28 Billion USD	4.59%
2005 Q3	12.18 Billion USD	-1.9%
2005 Q2	12.42 Billion USD	-5.09%
2005 Q1	13.09 Billion USD	-12.28%
2005 FY	51.29 Billion USD	-2.32%
2005 Q4	13.59 Billion USD	11.52%
2004 FY	52.51 Billion USD	16.22%
2004 Q4	14.92 Billion USD	16.3%
2004 Q3	12.83 Billion USD	4.54%
2004 Q2	12.27 Billion USD	-1.71%
2004 Q1	12.48 Billion USD	-11.85%
2003 Q2	9.99 Billion USD	17.22%
2003 Q4	14.16 Billion USD	13.29%
2003 Q3	12.5 Billion USD	25.13%
2003 FY	45.18 Billion USD	39.59%
2003 Q1	8.52 Billion USD	18.47%
2002 FY	32.37 Billion USD	0.35%
2002 Q3	8.72 Billion USD	8.61%
2002 Q1	8.41 Billion USD	-6.78%
2002 Q4	7.19 Billion USD	-17.52%
2002 Q2	8.03 Billion USD	-4.57%
2001 Q1	7.64 Billion USD	-5.69%
2001 Q2	7.68 Billion USD	0.54%
2001 Q4	9.03 Billion USD	14.33%
2001 FY	32.25 Billion USD	9.08%
2001 Q3	7.89 Billion USD	2.76%
2000 Q2	7.04 Billion USD	63.17%
2000 FY	29.57 Billion USD	82.51%
2000 Q4	8.1 Billion USD	12.51%
2000 Q3	7.2 Billion USD	2.33%
2000 Q1	4.31 Billion USD	-4.26%
1999 Q1	3.92 Billion USD	1.58%
1999 Q3	3.99 Billion USD	5.64%
1999 FY	16.2 Billion USD	19.64%
1999 Q2	3.77 Billion USD	-3.77%
1999 Q4	4.5 Billion USD	12.9%
1998 Q1	3.33 Billion USD	-4.49%
1998 FY	13.54 Billion USD	8.32%
1998 Q2	3.63 Billion USD	8.81%
1998 Q3	3.33 Billion USD	-8.34%
1998 Q4	3.86 Billion USD	16.1%
1997 FY	12.5 Billion USD	10.6%
1997 Q2	2.91 Billion USD	-2.96%
1997 Q3	3.09 Billion USD	6.21%
1997 Q4	3.49 Billion USD	12.99%
1997 Q1	3 Billion USD	-5.0%
1996 Q1	2.68 Billion USD	-2.27%
1996 Q3	2.8 Billion USD	5.34%
1996 Q4	3.16 Billion USD	12.74%
1996 FY	11.3 Billion USD	12.82%
1996 Q2	2.66 Billion USD	-0.78%
1995 Q3	2.53 Billion USD	2.28%
1995 Q1	2.4 Billion USD	4.46%
1995 FY	10.02 Billion USD	21.01%
1995 Q4	2.74 Billion USD	8.11%
1995 Q2	2.48 Billion USD	3.29%
1994 Q4	2.3 Billion USD	10.86%
1994 FY	8.28 Billion USD	10.75%
1994 Q3	2.07 Billion USD	7.88%
1994 Q2	1.92 Billion USD	-3.01%
1994 Q1	1.98 Billion USD	-0.32%
1993 Q3	1.87 Billion USD	7.08%
1993 Q2	1.74 Billion USD	-6.35%
1993 Q4	1.98 Billion USD	6.23%
1993 FY	7.47 Billion USD	3.42%
1993 Q1	1.86 Billion USD	-4.1%
1992 FY	7.23 Billion USD	4.03%
1992 Q3	1.82 Billion USD	7.87%
1992 Q2	1.69 Billion USD	-3.81%
1992 Q1	1.76 Billion USD	-4.8%
1992 Q4	1.94 Billion USD	6.54%
1991 Q1	1.69 Billion USD	-5.02%
1991 Q2	1.63 Billion USD	-3.81%
1991 Q3	1.77 Billion USD	8.7%
1991 Q4	1.85 Billion USD	4.35%
1991 FY	6.95 Billion USD	8.49%
1990 FY	6.4 Billion USD	12.95%
1990 Q4	1.78 Billion USD	8.66%
1990 Q3	1.64 Billion USD	9.85%
1990 Q2	1.49 Billion USD	0.92%
1990 Q1	1.48 Billion USD	-0.8%
1989 Q1	1.43 Billion USD	4.98%
1989 Q2	1.3 Billion USD	-9.3%
1989 FY	5.67 Billion USD	5.31%
1989 Q4	1.49 Billion USD	3.86%
1989 Q3	1.43 Billion USD	10.42%

Peer Revenue Comparison of Pfizer Inc.

Name	Revenue	Revenue Difference
AbbVie Inc.	54.31 Billion USD	-7.692%
Bristol-Myers Squibb Company	45 Billion USD	-29.974%
Bristol-Myers Squibb Company Ce	45 Billion USD	-29.974%
Johnson & Johnson	85.15 Billion USD	31.31%
Eli Lilly and Company	34.12 Billion USD	-71.421%
Merck & Co., Inc.	60.11 Billion USD	2.693%
Novartis AG	46.66 Billion USD	-25.366%
Organon & Co.	6.26 Billion USD	-833.993%

Global Stocks Search

Pfizer Inc. (PFE)

Revenue Summary of Pfizer Inc.

Annual Revenue Chart of Pfizer Inc. (2023 - 1989)

Historical Annual Revenue of Pfizer Inc. (2023 - 1989)

Peer Revenue Comparison of Pfizer Inc.